Cargando…
Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target
Cancer stem cells (CSCs) are subpopulations of tumor cells that possess abilities for self-renewal, differentiation, and tumor initiation. These rare but therapy-recalcitrant cells are assumed to repopulate tumors following administration of systemic chemotherapy driving therapy failure, tumor recur...
Autores principales: | Domrachev, Bogdan, Singh, Sitanshu, Li, Dandan, Rudloff, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168947/ https://www.ncbi.nlm.nih.gov/pubmed/34079928 http://dx.doi.org/10.29245/2578-2967/2021/1.1194 |
Ejemplares similares
-
Phosphoinositide‐dependent Kinase‐1 (PDPK1) regulates serum/glucocorticoid‐regulated Kinase 3 (SGK3) for prostate cancer cell survival
por: Nalairndran, Geetha, et al.
Publicado: (2020) -
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
por: Li, Dandan, et al.
Publicado: (2018) -
Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery
por: Atiya, Akhtar, et al.
Publicado: (2022) -
Downregulating PDPK1 and taking phillyrin as PDPK1-targeting drug protect hepatocytes from alcoholic steatohepatitis by promoting autophagy
por: Zhang, Yuan, et al.
Publicado: (2022) -
3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
por: Fyffe, Chanse, et al.
Publicado: (2013)